These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 15930340)
41. Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles. May T; Shoni M; Crum CP; Xian W; Vathipadiekal V; Birrer M; Rosen B; Tone A; Murphy KJ Gynecol Oncol; 2013 Mar; 128(3):488-92. PubMed ID: 23253401 [TBL] [Abstract][Full Text] [Related]
42. Laser capture microdissection with genome-wide expression profiling displayed gene expression signatures in endometrioid endometrial cancer. Mokhtar NM; Ramzi NH; Yin-Ling W; Rose IM; Hatta Mohd Dali AZ; Jamal R Cancer Invest; 2012 Feb; 30(2):156-64. PubMed ID: 22122087 [TBL] [Abstract][Full Text] [Related]
43. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038 [TBL] [Abstract][Full Text] [Related]
44. Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Ferguson SE; Olshen AB; Viale A; Awtrey CS; Barakat RR; Boyd J Gynecol Oncol; 2004 Feb; 92(2):719-25. PubMed ID: 14766275 [TBL] [Abstract][Full Text] [Related]
45. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630 [TBL] [Abstract][Full Text] [Related]
46. Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carcinoma: a rare association. Arora P; Rao S; Khurana N; Talwar D; Tanwar R J Cancer Res Ther; 2011; 7(1):88-91. PubMed ID: 21546752 [TBL] [Abstract][Full Text] [Related]
47. Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells. Davies S; Dai D; Pickett G; Leslie KK Gynecol Oncol; 2006 Apr; 101(1):62-70. PubMed ID: 16289307 [TBL] [Abstract][Full Text] [Related]
49. A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue. Sugiyama Y; Dan S; Yoshida Y; Akiyama F; Sugiyama K; Hirai Y; Matsuura M; Miyata S; Ushijima M; Hasumi K; Yamori T Clin Cancer Res; 2003 Nov; 9(15):5589-600. PubMed ID: 14654540 [TBL] [Abstract][Full Text] [Related]
50. Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure. Fles R; Hoogendoorn WE; Platteel I; Scheerman CE; de Leeuw-Mantel G; Mourits MJ; Hollema H; van Leeuwen FE; van Boven HH; Nederlof PM Genes Chromosomes Cancer; 2010 Aug; 49(8):699-710. PubMed ID: 20544844 [TBL] [Abstract][Full Text] [Related]
51. PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma. Chivukula M; Dabbs DJ; O'Connor S; Bhargava R Int J Gynecol Pathol; 2009 Nov; 28(6):570-8. PubMed ID: 19851209 [TBL] [Abstract][Full Text] [Related]
52. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma. Shih IeM; Wang TL J Pathol; 2011 May; 224(1):1-4. PubMed ID: 21432855 [TBL] [Abstract][Full Text] [Related]
54. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma. Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343 [TBL] [Abstract][Full Text] [Related]
55. Correspondence re: Mikami Y, Hata S, Kiyokawa T, Manabe T. Expression of CD10 in malignant mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod pathol 2002;15:923-30. Zamecnik M Mod Pathol; 2003 Jun; 16(6):618-9; author reply 619. PubMed ID: 12808069 [No Abstract] [Full Text] [Related]
56. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Drapkin R; von Horsten HH; Lin Y; Mok SC; Crum CP; Welch WR; Hecht JL Cancer Res; 2005 Mar; 65(6):2162-9. PubMed ID: 15781627 [TBL] [Abstract][Full Text] [Related]
57. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy. Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498 [TBL] [Abstract][Full Text] [Related]
58. Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma. Mhawech-Fauceglia P; Wang D; Kesterson J; Syriac S; Clark K; Frederick PJ; Lele S; Liu S PLoS One; 2011 Mar; 6(3):e18066. PubMed ID: 21448288 [TBL] [Abstract][Full Text] [Related]
59. Sulfatase activity in normal and neoplastic endometrium. Abulafia O; Lee YC; Wagreich A; Economos K; Serur E; Nacharaju VL Gynecol Obstet Invest; 2009; 67(1):57-60. PubMed ID: 18843186 [TBL] [Abstract][Full Text] [Related]
60. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature. Hornreich G; Beller U; Lavie O; Renbaum P; Cohen Y; Levy-Lahad E Gynecol Oncol; 1999 Nov; 75(2):300-4. PubMed ID: 10525392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]